NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCATS E-118-2019-0-US-01 SMALL MOLECULE BET BROMODOMAIN INHIBITORS AND USES THEREOF US 62/838,083 Abandoned
NIAID E-018-2018-0-TW-03 CHIMERIC VECTORS TW ORD 108114132 Issued
NIAID E-051-2002-0-US-19 METHODS FOR USING EXTRACELLULAR ADENOSINE INHIBITORS AND
ADENOSINE RECEPTOR INHIBITORS TO ENHANCE IMMUNE RESPONSE AND
INFLAMMATION 		US CON 16/391,423 11471528 Expired PDF
NCI E-750-2013-0-EP-11 Methods for Subtyping Lymphoma Types by Means of Expression Profiling EP DIV 19170689.4 Issued
NCI E-750-2013-0-GB-24 Methods for Subtyping Lymphoma Types by Means of Expression Profiling GB EP 19170689.4 Issued
NCI E-750-2013-0-ES-22 Methods for Subtyping Lymphoma Types by Means of Expression Profiling ES EP 19170689.4 Issued
NCI E-750-2013-0-DE-21 Methods for Subtyping Lymphoma Types by Means of Expression Profiling DE EP 19170689.4 Issued
NCI E-750-2013-0-FR-23 Methods for Subtyping Lymphoma Types by Means of Expression Profiling FR EP 19170689.4 Issued
NIAID E-018-2018-0-PCT-02 CHIMERIC VECTORS PCT PCT PCT/US2019/028771 Expired
NCI E-122-2018-0-PCT-02 COMPOSITIONS AND METHODS FOR MODULATINGvENDOPLASMIC RETICULUM-ASSOCIATED DEGRADATION PCT PCT PCT/US2019/028690 Expired
NCATS E-193-2018-0-PCT-02 Improved CRISPR Therapy PCT PCT PCT/US2019/028635 Expired
NIMH E-107-2019-0-US-01 PDE4D INHIBITORS US 62/837,352 Abandoned
NICHD E-003-2014-0-US-07 CARTILAGE TARGETING AGENTS AND THEIR USE US DIV 16/391,101 10954291 Issued PDF
NHGRI E-243-2012-0-US-18 SYNTHETIC METHYLMALONYL-COA MUTASE TRANSGENE FOR THE TREATMENT OF MUT CLASS METHYLMALONIC ACIDEMIA (MMA) US CON 16/390,917 10894077 Issued PDF
NIA E-205-2006-2-US-27 Preparation Of R,R-fenoterol And R,R-fenoterol Analogues And Their Use In Congestive Heart Failure US CON 16/390,982 10562843 Issued PDF
NCI E-094-2018-0-PCT-02 METHODS OF PRODUCING T CELL POPULATIONS USING HYDROXYCITRIC ACID AND/OR A SALT THEREOF PCT PCT PCT/US2019/028513 Expired
NCI E-056-2011-0-US-02 YEAST-BRACHYURY IMMUNOTHERAPEUTIC COMPOSITIONS US CON 16/389,235 11944673 Issued PDF
NCI E-173-2018-2-US-02 Viral Methods Of T Cell Therapy US CON 16/389,586 Abandoned
NIBIB E-005-2012-2-US-08 ILLUMINATION MICROSCOPY SYSTEMS AND METHODS US CON 16/387,842 10656403 Issued PDF
NHLBI E-114-2019-0-US-01 A Pre-emphasis Technique Based On The Temperature-dependent Gradient System Behavior For Trajectory Correction In MR Imaging US 62/835,882 Abandoned
NHLBI E-211-2018-4-US-02 Methods Of Inhibiting Viruses Using Compositions Targeting TSG101-Ubiquitin Interaction US National Stage 16/342,695 12059413 Issued PDF
NIA E-249-2016-0-US-14 METHODS OF DELIVERING A NEUROPROTECTIVE POLYPEPTIDE TO THE CENTRAL NERVOUS SYSTEM US National Stage 16/342,685 11273130 Issued PDF
NIAID E-101-2018-0-US-04 Multi-Specific Antibodies Targeting Human Immunodeficiency Virus And Methods Of Using The Same US National Stage 16/342,962 11149082 Issued PDF
NIAID E-297-2016-2-AU-02 VACCINE CANDIDATES FOR HUMAN RESPIRATORY SYNCYTIAL VIRUS (RSV) HAVING ATTENUATED PHENOTYPES AU National Stage 2017332789 Issued
NIAID E-297-2016-2-EP-03 VACCINE CANDIDATES FOR HUMAN RESPIRATORY SYNCYTIAL VIRUS (RSV) HAVING ATTENUATED PHENOTYPES EP National Stage 17778443.6 Pending
NIAID E-203-2020-0-US-01 Star Co-polymers For Ligand Display And Small Molecule Drug Delivery US 62/835,268 Abandoned
NIA E-249-2016-0-MX-11 METHODS OF DELIVERING A NEUROPROTECTIVE POLYPEPTIDE TO
THE CENTRAL NERVOUS SYSTEM 		MX National Stage MX/a/2019/004476 Issued
NCI E-238-2015-0-US-08 MOLECULAR NANOTAGS US National Stage 16/342,345 11536719 Issued PDF
NIDA E-077-2019-0-US-01 D3 RECEPTOR AGONIST COMPOUNDS; METHODS OF PREPARATION; INTERMEDIATES THEREOF; AND METHODS OF USE THEREOF US 62/833,023 Abandoned
CC E-184-2012-0-US-11 IMAGEABLE EMBOLIC MICROSPHERE US CON 16/381,204 Abandoned
NLM E-107-2010-2-US-28 SELECTIVE OXIDATION OF 5-METHYLCYTOSINE BY TET -FAMILY PROTEINS US CON 16/380,846 11072818 Issued PDF
NCATS E-091-2016-0-US-07 COMPOUNDS AND METHOD FOR BLOCKING TRANSMISSION OF MALARIAL PARASITE US National Stage 16/341,000 10988472 Abandoned PDF
NCI E-065-2019-0-US-01 HYBRID NUCLEIC ACID SWITCHES US 62/832,171 Abandoned
NCI E-276-2016-0-US-05 HPPK INHIBITORS USEFUL AS ANTIBACTERIAL AGENTS US National Stage 16/340,493 11091509 Issued PDF
NCI E-113-2018-0-PCT-02 COMBINATION OF NEAR INFRARED PHOTOIMMUNOTHERAPY TARGETING CANCER CELLS AND HOST-IMMUNE ACTIVATION PCT PCT PCT/US2019/026488 Expired
NCI E-113-2018-0-CN-05 COMBINATION OF NEAR INFRARED PHOTOIMMUNOTHERAPY TARGETING CANCER CELLS AND HOST-IMMUNE ACTIVATION CN National Stage 201980039324.7 Abandoned
NCI E-113-2018-0-EP-06 COMBINATION OF NEAR INFRARED PHOTOIMMUNOTHERAPY TARGETING CANCER CELLS AND HOST-IMMUNE ACTIVATION EP National Stage 19723538.5 Abandoned
NCI E-113-2018-0-JP-07 COMBINATION OF NEAR INFRARED PHOTOIMMUNOTHERAPY TARGETING CANCER CELLS AND HOST-IMMUNE ACTIVATION JP National Stage 2020-555199 Abandoned
NCI E-113-2018-0-CA-04 COMBINATION OF NEAR INFRARED PHOTOIMMUNOTHERAPY TARGETING CANCER CELLS AND HOST-IMMUNE ACTIVATION CA National Stage 3096305 Abandoned
NCI E-113-2018-0-AU-03 COMBINATION OF NEAR INFRARED PHOTOIMMUNOTHERAPY TARGETING CANCER CELLS AND HOST-IMMUNE ACTIVATION AU National Stage 2019253681 Abandoned
NIAID E-066-2020-0-US-01 Improvement Of Trispecific Antibodies To HIV-1 By Engraftment Of The FR3 Loop Of VRC03 (FR3-03) US 62/831,415 Abandoned
NCI E-062-2019-3-AU-02 Method Of Treating Urothelial And Other Genitourinary Carcinomas Using N-(4-(6,7-dimethoxyquinolin-4-yloxy)phenyl)-N’-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide AU National Stage 2017336547 Abandoned
NCI E-062-2019-3-NZ-06 Method Of Treating Urothelial Carcinoma And Other Genitourinary Malignancies Using N-(4-(6,7-dimethoxyquinolin-4-yloxy)phenyl)-N’-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide NZ National Stage 752345 Abandoned
NCI E-271-2014-0-US-03 A New Class Of Stable Heptamethine Cyanine Fluorophores And Biomedical Applications Thereof US CON 16/374,642 10876003 Issued PDF
NCI E-173-2015-0-US-04 Module For Freezing And Storage Of Frozen Tissue US National Stage 16/338,860 11802821 Issued PDF
NIAID E-279-2016-1-US-03 HIV-1 ENV FUSION PEPTIDE IMMUNOGENS AND THEIR USE US National Stage 16/338,964 11602559 Issued PDF
NIAID E-031-2026-0-PC-01 Antigenic Epstein Barr Virus Polypeptides PCT PCT PCT/US2019/025419 Expired
NHLBI E-078-2019-0-PCT-02 HELICAL GUIDEWIRES AND RELATED SYSTEMS PCT PCT PCT/US2019/025383 Expired
NIAID E-031-2026-0-CN-01 Antigenic Epstein Barr Virus Polypeptides CN National Stage 201980035124.4 Pending
NCATS E-120-2018-0-US-01 Remodelins, A New Class Of Compounds To Prevent Airway Remodeling And To Prevent Fibrosis In Multiple Organs US 62/827,980 Abandoned